PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+0.32%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$1.83B
AUM Growth
+$1.83B
(-8.7%)
Cap. Flow
-$69.5M
Cap. Flow
% of AUM
-3.79%
Top 10 Holdings %
Top 10 Hldgs %
48.51%
Holding
93
New
6
Increased
23
Reduced
12
Closed
14
Top Buys
| 1 |
UnitedHealth
UNH
|
$25.5M |
| 2 |
Amgen
AMGN
|
$25.3M |
| 3 |
Stryker
SYK
|
$20.1M |
| 4 |
Johnson & Johnson
JNJ
|
$18.8M |
| 5 |
Insmed
INSM
|
$16.2M |
Top Sells
| 1 |
Legend Biotech
LEGN
|
$41.2M |
| 2 |
Zimmer Biomet
ZBH
|
$39.6M |
| 3 |
Avantor
AVTR
|
$34.3M |
| 4 |
Veeva Systems
VEEV
|
$27.5M |
| 5 |
iShares Russell 2000 ETF
IWM
|
$20.8M |
Sector Composition
| 1 | Healthcare | 97.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Eli Lilly
LLY
$657B
| $270M | 13.38% | 298,643 | – | – |
|
2
Cytokinetics
CYTK
$4.23B
| $95.2M | 4.71% | 1,757,192 | – | – |
|
3
Tenet Healthcare
THC
$16.3B
| $78.4M | 3.88% | 589,409 | – | – |
|
4
Merck
MRK
$210B
| $73.8M | 3.65% | 596,261 | – | – |
|
5
Vertex Pharmaceuticals
VRTX
$100B
| $69.8M | 3.45% | 148,852 | – | – |
|
6
AbbVie
ABBV
$372B
| $69.3M | 3.43% | 403,861 | – | – |
|
7
Edwards Lifesciences
EW
$47.8B
| $68.4M | 3.38% | 740,260 | – | – |
|
8
Intuitive Surgical
ISRG
$170B
| $61.1M | 3.02% | 137,327 +26,290 | +24% | +$11.7M |
|
9
McKesson
MCK
$85.4B
| $56.9M | 2.82% | 97,498 | – | – |
|
10
Humana
HUM
$36.5B
| $46.8M | 2.32% | 125,340 | – | – |
|
11
HCA Healthcare
HCA
$94.5B
| $40.1M | 1.98% | 124,840 | – | – |
|
12
Centene
CNC
$14.3B
| $39.7M | 1.96% | 598,513 | – | – |
|
13
Universal Health Services
UHS
$11.6B
| $39.6M | 1.96% | 213,983 | – | – |
|
|
14
Stryker
SYK
$150B
| $38.9M | 1.92% | 114,297 +59,205 | +107% | +$20.1M |
|
15
Axsome Therapeutics
AXSM
$6.05B
| $37.6M | 1.86% | 467,427 | – | – |
|
16
argenx
ARGX
$43.6B
| $37.3M | 1.85% | 86,832 | – | – |
|
17
Icon
ICLR
$13.8B
| $36.5M | 1.81% | 116,532 +806 | +0.7% | +$253K |
|
|
18
UnitedHealth
UNH
$281B
| $35.4M | 1.75% | 69,438 +50,077 | +259% | +$25.5M |
|
19
Thermo Fisher Scientific
TMO
$186B
| $35.2M | 1.74% | 63,650 +5,612 | +10% | +$3.1M |
|
20
Penumbra
PEN
$10.6B
| $33.3M | 1.65% | 185,111 +29,325 | +19% | +$5.28M |
|
21
Danaher
DHR
$147B
| $31.4M | 1.55% | 125,515 | – | – |
|
22
Becton Dickinson
BDX
$55.3B
| $30.7M | 1.52% | 131,378 -40,174 | -23% | -$9.39M |
|
23
Elevance Health
ELV
$71.8B
| $29.9M | 1.48% | 55,250 | – | – |
|
24
Acadia Healthcare
ACHC
$2.12B
| $28.4M | 1.4% | 420,164 +152,430 | +57% | +$10.3M |
|
25
Boston Scientific
BSX
$156B
| $26.8M | 1.33% | 348,107 +175,321 | +101% | +$13.5M |
|